Overexpression of CD38 decreases cellular NAD levels and alters the expression of proteins involved in energy metabolism and antioxidant defense

Journal of Proteome Research

Volumn 13, Issue 2, 2014, Pages 786-795

  Hu, Yadong ^a   Wang, Helin ^a   Wang, Qingtao ^b   Deng, Haiteng ^a  

^a TSINGHUA UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

CD38; chaperones; glycolytic enzymes; oxidative stress; proteomics

Indexed keywords

ANTIGENS, CD38; ANTIOXIDANTS; BLOTTING, WESTERN; DNA REPAIR; ENERGY METABOLISM; HEK293 CELLS; HUMANS; NAD; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION;

EID: 84893854576     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr4010597     Document Type: Article

References (51)

1. Berger, F.; RamIrez-Hernandez, M. H.; Ziegler, M. The new life of a centenarian: signalling functions of NAD (P) Trends Biochem. Sci. 2004, 29 (3) 111-118
2. Belenky, P.; Bogan, K. L.; Brenner, C. NAD+ metabolism in health and disease Trends Biochem. Sci. 2007, 32 (1) 12-19
3. Chiarugi, A.; Dölle, C.; Felici, R.; Ziegler, M. The NAD metabolome-a key determinant of cancer cell biology Nat. Rev. Cancer 2012, 12 (11) 741-752
4. Lin, H. Nicotinamide adenine dinucleotide: beyond a redox coenzyme Org. Biomol. Chem. 2007, 5 (16) 2541-2554
5. Ying, W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences Antioxid. Redox Signaling 2008, 10 (2) 179-206
6. Xia, W.; Wang, Z.; Wang, Q.; Han, J.; Zhao, C.; Hong, Y.; Zeng, L.; Tang, L.; Ying, W. Roles of NAD+/NADH and NADP+/NADPH in Cell Death Curr. Pharm. Des. 2009, 15 (1) 12-19
7. Sauve, A. A.; Deng, H.; Angeletti, R. H.; Schramm, V. L. A covalent intermediate in CD38 is responsible for ADP-ribosylation and cyclization reactions J. Am. Chem. Soc. 2000, 122 (33) 7855-7859
8. Dong, M.; Si, Y.; Sun, S.; Pu, X.; Yang, Z.; Zhang, L.; Zhang, L.; Leung, F.; Lam, C. M. C.; Kwong, A. K. Y. Design, synthesis and biological characterization of novel inhibitors of CD38 Org. Biomol. Chem. 2011, 9 (9) 3246-3257
9. Blander, G.; Guarente, L. The Sir2 family of protein deacetylases Annu. Rev. Biochem. 2004, 73 (1) 417-435
10. Moazed, D. Enzymatic activities of Sir2 and chromatin silencing Curr. Opin. Cell Biol. 2001, 13 (2) 232-238
11. Sauve, A. A.; Celic, I.; Avalos, J.; Deng, H.; Boeke, J. D.; Schramm, V. L. Chemistry of gene silencing: the mechanism of NAD+-dependent deacetylation reactions Biochemistry 2001, 40 (51) 15456-15463
12. Denu, J. M. The Sir2 family of protein deacetylases Curr. Opin. Chem. Biol. 2005, 9 (5) 431-440
13. Guarente, L. Sirtuins and calorie restriction Nat. Rev. Mol. Cell Biol. 2012, 13 (4) 207
14. Chalkiadaki, A.; Guarente, L. Sirtuins mediate mammalian metabolic responses to nutrient availability Nat. Rev. Endocrinol. 2012, 8 (5) 287-296
15. Yang, T.; Sauve, A. A. NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity AAPS J. 2006, 8 (4) E632-E643
16. Herranz, D.; Serrano, M. SIRT1: recent lessons from mouse models Nat. Rev. Cancer 2010, 10 (12) 819-823
17. Rahman, S.; Islam, R. Mammalian Sirt1: insights on its biological functions Cell Commun. Signal 2011, 9 (11) 11
18. Zhang, T.; Kraus, W. L. SIRT1-dependent regulation of chromatin and transcription: Linking NAD+ metabolism and signaling to the control of cellular functions Biochim. Biophys Acta, Proteins Proteomics 2010, 1804 (8) 1666-1675
19. Milner, J. Cellular regulation of SIRT1 Curr. Pharm. Des. 2009, 15 (1) 39-44
20. Saunders, L.; Verdin, E. Sirtuins: critical regulators at the crossroads between cancer and aging Oncogene 2007, 26 (37) 5489-5504
21. Haigis, M. C.; Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance Annu. Rev. Pathol. 2010, 5, 253-295
22. McGuinness, D.; McGuinness, D.; McCaul, J.; Shiels, P. Sirtuins, bioageing, and cancer J. Aging Res. 2011, 2011
23. Qin, W.; Yang, T.; Ho, L.; Zhao, Z.; Wang, J.; Chen, L.; Zhao, W.; Thiyagarajan, M.; MacGrogan, D.; Rodgers, J. T. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction J. Biol. Chem. 2006, 281 (31) 21745-21754
24. Sauve, A. A. Pharmaceutical strategies for activating sirtuins Curr. Pharm. Des. 2009, 15 (1) 45-56
25. Lavu, S.; Boss, O.; Elliott, P. J.; Lambert, P. D. Sirtuins-novel therapeutic targets to treat age-associated diseases Nat. Rev. Drug Discovery 2008, 7 (10) 841-853
26. Uhl, M.; Csernok, A.; Aydin, S.; Kreienberg, R.; Wiesmüller, L.; Gatz, S. A. Role of SIRT1 in homologous recombination DNA Repair 2010, 9 (4) 383-393
27. Kim, H.; Vassilopoulos, A.; Wang, R.; Lahusen, T.; Xiao, Z.; Xu, X.; Li, C.; Veenstra, T. D.; Li, B.; Yu, H. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity Cancer Cell 2011, 20 (4) 487-499
28. Leiser, S. F.; Kaeberlein, M. A role for SIRT1 in the hypoxic response Mol. Cell 2010, 38 (6) 779-780
29. Li, X.; Kazgan, N. Mammalian sirtuins and energy metabolism Int. J. Biol. Sci. 2011, 7 (5) 575-587
30. Verdin, E.; Hirschey, M. D.; Finley, L. W.; Haigis, M. C. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling Trends Biochem. Sci. 2010, 35 (12) 669-675
31. Brooks, C. L.; Gu, W. How does SIRT1 affect metabolism, senescence and cancer? Nat. Rev. Cancer 2008, 9 (2) 123-128
32. Yang, H.; Yang, T.; Baur, J. A.; Perez, E.; Matsui, T.; Carmona, J. J.; Lamming, D. W.; Souza-Pinto, N. C.; Bohr, V. A.; Rosenzweig, A. Nutrient-Sensitive Mitochondrial NAD+ Levels Dictate Cell Survival Cell 2007, 130 (6) 1095-1107
33. Chang, H.; Guarente, L. SIRT1Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging Cell 2013, 153 (7) 1448-1460
34. Luo, X.; Kraus, W. L. On PAR with PARP: cellular stress signaling through poly (ADP-ribose) and PARP-1 Genes Dev. 2012, 26 (5) 417-432
35. Cantó, C.; Sauve, A. A.; Bai, P. Crosstalk between poly (ADP-ribose) polymerase and sirtuin enzymes Mol. Aspects Med. 2013, 34 (6) 1168-1201
36. Aksoy, P.; White, T. A.; Thompson, M.; Chini, E. N. Regulation of intracellular levels of NAD: a novel role for CD38 Biochem. Biophys. Res. Commun. 2006, 345 (4) 1386-1392
37. Chini, E. N. CD38 as a regulator of cellular NAD: a novel potential pharmacological target for metabolic conditions Curr. Pharm. Des. 2009, 15 (1) 57-63
38. Agrimi, G.; Brambilla, L.; Frascotti, G.; Pisano, I.; Porro, D.; Vai, M.; Palmieri, L. Deletion or overexpression of mitochondrial NAD+ carriers in Saccharomyces cerevisiae alters cellular NAD and ATP contents and affects mitochondrial metabolism and the rate of glycolysis Appl. Environ. Microbiol. 2011, 77 (7) 2239-2246
39. Tiscornia, G.; Singer, O.; Verma, I. M. Production and purification of lentiviral vectors Nat. Protoc. 2006, 1 (1) 241-245
40. Sun, F.; Dai, C.; Xie, J.; Hu, X. Biochemical issues in estimation of cytosolic free NAD/NADH ratio PloS One 2012, 7 (5) e34525
41. Lin, S. J.; Guarente, L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease Curr. Opin. Cell Biol. 2003, 15 (2) 241-246
42. Jang, S. Y.; Kang, H. T.; Hwang, E. S. Nicotinamide-induced Mitophagy event mediated by high NAD+/NADH ratio and SIRT1 protein activation J. Biol. Chem. 2012, 287 (23) 19304-19314
43. Christofk, H. R.; Vander Heiden, M. G.; Harris, M. H.; Ramanathan, A.; Gerszten, R. E.; Wei, R.; Fleming, M. D.; Schreiber, S. L.; Cantley, L. C. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth Nature 2008, 452 (7184) 230-233
44. Ge, Y.; Jiang, W.; Gan, L.; Wang, L.; Sun, C.; Ni, P.; Liu, Y.; Wu, S.; Gu, L.; Zheng, W. Mouse embryonic fibroblasts from CD38 knockout mice are resistant to oxidative stresses through inhibition of reactive oxygen species production and Ca2+ overload Biochem. Biophys. Res. Commun. 2010, 399 (2) 167-172
45. Koll, H.; Guiard, B.; Rassow, J.; Ostermann, J.; Horwich, A. L.; Neupert, W.; Hartl, F.-U. Antifolding activity of hsp60 couples protein import into the mitochondrial matrix with export to the intermembrane space Cell 1992, 68 (6) 1163-1175
46. Calabrese, V.; Mancuso, C.; Ravagna, A.; Perluigi, M.; Cini, C.; Marco, C. D.; Allan Butterfield, D.; Stella, A. M. G. In vivo induction of heat shock proteins in the substantia nigra following L-DOPA administration is associated with increased activity of mitochondrial complex I and nitrosative stress in rats: regulation by glutathione redox state J. Neurochem. 2007, 101 (3) 709-717
47. Rossi, M. R.; Somji, S.; Garrett, S. H.; Sens, M. A.; Nath, J.; Sens, D. A. Expression of hsp 27, hsp 60, hsc 70, and hsp 70 stress response genes in cultured human urothelial cells (UROtsa) exposed to lethal and sublethal concentrations of sodium arsenite Environ. Health Perspect. 2002, 110 (12) 1225-1232
48. Chandra, D.; Choy, G.; Tang, D. G. Cytosolic accumulation of hsp60 during apoptosis with or without apparent mitochondrial release: Evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase J. Biol. Chem. 2007, 282 (43) 31289-31301
49. Satelli, A.; Li, S. Vimentin in cancer and its potential as a molecular target for cancer therapy Cell. Mol. Life Sci. 2011, 68 (18) 3033-3046
50. Verrills, N. M.; Walsh, B. J.; Cobon, G. S.; Hains, P. G.; Kavallaris, M. Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations J. Biol. Chem. 2003, 278 (46) 45082-45093
51. Urbani, A.; Poland, J.; Bernardini, S.; Bellincampi, L.; Biroccio, A.; Schnölzer, M.; Sinha, P.; Federici, G. A proteomic investigation into etoposide chemo-resistance of neuroblastoma cell lines Proteomics 2005, 5 (3) 796-804